Scarica l'app Stockscreener
238.57
3.33%
-8.23
Dopo l'orario di chiusura:
250.49
11.92
+5.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Insulet Corporation Borsa (PODD) Ultime notizie
Study Data Show Significant Glycemic Improvements With Omnipod 5 - Medical Product Outsourcing
RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating - marketscreener.com
What's Driving the Market Sentiment Around Insulet? - Benzinga
Insulet Announces Proposal for Upcoming Financing Deals - The Healthcare Technology Report.
Schroder Investment Management Group Decreases Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insider Sell: Insulet - marketscreener.com
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know - Yahoo Finance
Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? - Nasdaq
Insulet's Market Expansion: The Omnipod Impact on Diabetes Care - marketscreener.com
Insulet's $389 Million Trading Day Lands 450th in Market Rankings - AInvest
Ex-Insulet CTO Mark Field has a new job in medtech with ITJ - Medical Design & Outsourcing
PODD Stock Benefits From the Launch of Omnipod 5 in Canada - MSN
MedTechVets Announces Veteran Placement Partnership with Insulet - WebWire
GE Vernova, Insulet lead modest stock rebound amid tariff volatility - The Business Journals
Automated Insulin Delivery Systems - Trend Hunter
Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7% - Yahoo Finance
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above - The Malaysian Reserve
Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating - marketscreener.com
Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet? - simplywall.st
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
Insulin Tech Leader Insulet Readies Q1 2025 Results: What's Next for Omnipod Maker? - Stock Titan
(PODD) Trading Advice - news.stocktradersdaily.com
Insulet Stock: Is PODD Outperforming the Healthcare Sector? - Nasdaq
Insulet Stock: Is PODD Outperforming The Healthcare Sector? - Barchart.com
New Age Alpha Advisors LLC Buys Shares of 30,096 Insulet Co. (NASDAQ:PODD) - MarketBeat
3 Reasons Investors Love Insulet (PODD) - Yahoo Finance
Insulet director Frederick Wayne sells $501,875 in stock By Investing.com - Investing.com Canada
Insulet director Frederick Wayne sells $501,875 in stock - Investing.com
Insulet glows with RADIANT results, CGMs becoming T2D standard - BioWorld MedTech
Insulet Gains 62.9% in a Year: What's Driving the Stock? - Yahoo
Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5% - Yahoo Finance
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Insulet Corp issues $450 million in senior notes By Investing.com - Investing.com Canada
Insulet Corp (PODD)'s Winning Formula: Financial Metrics and Com - GuruFocus
PODD Stock Gains Following the Launch of Omnipod 5 in Australia - Yahoo Finance
Insulet Corp issues $450 million in senior notes - Investing.com India
Insulet Closes $450 Million Senior Notes Issuance - TipRanks
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers - Yahoo Finance
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 - Nasdaq
LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day - TradingView
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - BioSpace
Insulet's RADIANT Trial Results Highlight Significant Glycemic Benefits From Omnipod 5 Transition - Nasdaq
Omnipod 5 improves diabetes control in clinical trial By Investing.com - Investing.com South Africa
Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - Lelezard
Insulet says data shows significant glycemic improvement with Omnipod 5 - Seeking Alpha
Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System - Marketscreener.com
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):